Literature DB >> 8559593

Identification and properties of a neuropeptide-degrading endopeptidase (neprilysin) of Ascaris suum muscle.

M Sajid1, R E Isaac.   

Abstract

We have previously identified in membranes of the locomotory muscle of Ascaris suum a phosphoramidon-sensitive endopeptidase which hydrolyses the neuropeptide AF1 (Lys-Asn-Glu-Phe-Ile-Arg-Phe-NH2) by cleavage of the Glu3-Phe4 bond (Sajid & Isaac, 1994). We have determined the properties of this neuropeptide-degrading enzyme of A. suum muscle using AKH-1 (pGlu-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2) and [D-Ala2, Leu5]enkephalin as convenient endopeptidase substrates. Phosphoramidon, thiorphan and SQ 28603, potent inhibitors of mammalian neprilysin (neutral endopeptidase, endopeptidase 24.11), inhibited the endopeptidase activity towards AKH-I with IC50 values of 0.13 microM, 22 microM and 6.3 microM, respectively. Two other neprilysin inhibitors (SCH 32615 and SCH 39370) and the bivalent metal ion chelators, EDTA (1 mM) and 1, 10 bis-phenanthroline (1 mM) failed to inhibit the nematode enzyme. The endopeptidase had a neutral pH optimum and a significant proportion (45%) of the enzyme activity partitioned into the detergent-rich phase of Triton X-114, indicating that the enzyme is an integral membrane protein. The muscle enzyme also attacked [D-Ala2, Leu5]enkephalin cleaving the Gly3-Phe4 bond and this hydrolytic activity was inhibited by phosphoramidon and thiorphan (IC50, 0.28 microM and 15.8 microM, respectively) but not by EDTA and 1, 10 bis-phenanthroline. The phosphoramidon-sensitive endopeptidase activity was detected on intact muscle cells prepared by collagenase treatment of the body wall musculature, indicating that endopeptidase is accessible to peptide molecules that interact with the cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8559593     DOI: 10.1017/s0031182000077088

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  7 in total

1.  The gene structure and promoter region of the vaccine target aminopeptidase H11 from the blood-sucking nematode parasite of ruminants, Haemonchus contortus.

Authors:  Qian-Jin Zhou; Hong-Li Zhang; Xiao-Lei Jiang; Ai-Fang Du
Journal:  Funct Integr Genomics       Date:  2010-05-01       Impact factor: 3.410

2.  Drosophila melanogaster NEP2 is a new soluble member of the neprilysin family of endopeptidases with implications for reproduction and renal function.

Authors:  Josie E Thomas; Caroline M Rylett; Ahmet Carhan; Nicholas D Bland; Richard J Bingham; Alan D Shirras; Anthony J Turner; R Elwyn Isaac
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

3.  Characterization of Aminopeptidase in the Free-living Nematode Panagrellus redivivus: Subcellular Distribution and Possible Role in Neuropeptide Metabolism.

Authors:  E P Masler
Journal:  J Nematol       Date:  2007-06       Impact factor: 1.402

Review 4.  Parasite neuropeptide biology: Seeding rational drug target selection?

Authors:  Paul McVeigh; Louise Atkinson; Nikki J Marks; Angela Mousley; Johnathan J Dalzell; Ann Sluder; Lance Hammerland; Aaron G Maule
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-15       Impact factor: 4.077

5.  Bioinformatic analysis of the neprilysin (M13) family of peptidases reveals complex evolutionary and functional relationships.

Authors:  Nicholas D Bland; John W Pinney; Josie E Thomas; Anthony J Turner; R Elwyn Isaac
Journal:  BMC Evol Biol       Date:  2008-01-23       Impact factor: 3.260

6.  Analysis of survival and hatching transcriptomes from potato cyst nematodes, Globodera rostochiensis and G. pallida.

Authors:  Marc-Olivier Duceppe; Joël Lafond-Lapalme; Juan Emilio Palomares-Rius; Michaël Sabeh; Vivian Blok; Peter Moffett; Benjamin Mimee
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

7.  Emerging trends in sacubitril/valsartan research: A bibliometric analysis of the years 1995-2021.

Authors:  Ping Lai; Jin-Hua Xue; Mu-Jin Xie; Jin-Hua Ye; Ke-Jun Tian; Jia-Yuan Ling; Wen-Ting Zhong; Dong Chen; Yi-Ming Zhong; Yong-Ling Liao
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.